Molecular cancer therapy: Galectin-9 (hGal9) prolongs the half-life of tumor suppressor p53 homologue TA-p73β via up regulation of its target gene, 23/February/2014, 22.06

Molecular cancer therapy: Cyclosporin, a calcineurin inhibitor and an immunosuppressive agent, prolongs the half-life of tumor suppressor p53 homologue TA-p73β via up regulation of its target gene, 23/February/2014, 22.03
February 23, 2014
Molecular cancer therapy for tumor suppressor p53-mutated human Cancers: Berberine suppresses the oncogenic function of Mt-p53 (R175H and R273H) via up regulation of its target gene, 23/February/2014, 22.13
February 23, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan,  Molecular cancer therapy: Galectin-9 (hGal9) prolongs the half-life of tumor suppressor p53 homologue TA-p73β via up regulation of its target gene, 23/February/2014, 22.06, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.